APHENA PHARMA
Aphena Pharma, a prominent player in the pharmaceutical industry, is headquartered in the United States and operates extensively across North America. Founded in 2009, the company has established itself as a leader in contract manufacturing and packaging services, catering to a diverse range of clients in the healthcare sector. Aphena Pharma is renowned for its innovative approach to pharmaceutical solutions, offering a unique blend of services that include solid dose manufacturing, packaging, and labelling. The company’s commitment to quality and compliance has earned it a strong market position, with notable achievements in efficiency and customer satisfaction. With a focus on enhancing patient outcomes, Aphena Pharma continues to set benchmarks in the industry, making it a trusted partner for pharmaceutical companies seeking reliable and effective solutions.
DitchCarbon Score
How does APHENA PHARMA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
APHENA PHARMA's score of 3 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
APHENA PHARMA's reported carbon emissions
APHENA PHARMA, headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints. Companies are encouraged to adopt science-based targets and engage in climate pledges to mitigate their environmental impact. As APHENA PHARMA navigates this landscape, it may consider establishing measurable goals and reporting frameworks to enhance transparency and accountability in their climate commitments.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
APHENA PHARMA is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
